These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 39066795

  • 1. A novel Saclayvirus Acinetobacter baumannii phage genomic analysis and effectiveness in preventing pneumonia.
    Li S, Wei B, Xu L, Cong C, Murtaza B, Wang L, Li X, Li J, Xu M, Yin J, Xu Y.
    Appl Microbiol Biotechnol; 2024 Jul 27; 108(1):428. PubMed ID: 39066795
    [Abstract] [Full Text] [Related]

  • 2. Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates.
    Peng F, Mi Z, Huang Y, Yuan X, Niu W, Wang Y, Hua Y, Fan H, Bai C, Tong Y.
    BMC Microbiol; 2014 Jul 05; 14():181. PubMed ID: 24996449
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preclinical Assessment of Bacteriophage Therapy against Experimental Acinetobacter baumannii Lung Infection.
    Wienhold SM, Brack MC, Nouailles G, Krishnamoorthy G, Korf IHE, Seitz C, Wienecke S, Dietert K, Gurtner C, Kershaw O, Gruber AD, Ross A, Ziehr H, Rohde M, Neudecker J, Lienau J, Suttorp N, Hippenstiel S, Hocke AC, Rohde C, Witzenrath M.
    Viruses; 2021 Dec 24; 14(1):. PubMed ID: 35062236
    [Abstract] [Full Text] [Related]

  • 9. In Vivo Application of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357.
    Jeon J, Ryu CM, Lee JY, Park JH, Yong D, Lee K.
    Appl Environ Microbiol; 2016 Jul 15; 82(14):4200-4208. PubMed ID: 27208124
    [Abstract] [Full Text] [Related]

  • 10. Characterization of a Straboviridae phage vB_AbaM-SHI and its inhibition effect on biofilms of Acinetobacter baumannii.
    Jiang L, Xu Q, Wu Y, Zhou X, Chen Z, Sun Q, Wen J.
    Front Cell Infect Microbiol; 2024 Jul 15; 14():1351993. PubMed ID: 38524182
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia.
    Jeon J, Park JH, Yong D.
    BMC Microbiol; 2019 Apr 02; 19(1):70. PubMed ID: 30940074
    [Abstract] [Full Text] [Related]

  • 13. Characterization and efficacy against carbapenem-resistant Acinetobacter baumannii of a novel Friunavirus phage from sewage.
    Wang Z, Yang X, Wang H, Wang S, Fang R, Li X, Xing J, Wu Q, Li Z, Song N.
    Front Cell Infect Microbiol; 2024 Apr 02; 14():1382145. PubMed ID: 38736748
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Isolation and Characterization of a Novel Autographiviridae Phage and Its Combined Effect with Tigecycline in Controlling Multidrug-Resistant Acinetobacter baumannii-Associated Skin and Soft Tissue Infections.
    Wintachai P, Surachat K, Singkhamanan K.
    Viruses; 2022 Jan 20; 14(2):. PubMed ID: 35215788
    [No Abstract] [Full Text] [Related]

  • 17. Characterization and therapeutic potential of MRABP9, a novel lytic bacteriophage infecting multidrug-resistant Acinetobacter baumannii clinical strains.
    Zhang Y, Shao Y, You H, Shen Y, Miao F, Yuan C, Chen X, Zhai M, Shen Y, Zhang J.
    Virology; 2024 Jul 20; 595():110098. PubMed ID: 38705084
    [Abstract] [Full Text] [Related]

  • 18. Resistance to bacteriophage incurs a cost to virulence in drug-resistant Acinetobacter baumannii.
    Manley R, Fitch C, Francis V, Temperton I, Turner D, Fletcher J, Phil M, Michell S, Temperton B.
    J Med Microbiol; 2024 May 20; 73(5):. PubMed ID: 38743467
    [Abstract] [Full Text] [Related]

  • 19. Isolation and characterization of ZZ1, a novel lytic phage that infects Acinetobacter baumannii clinical isolates.
    Jin J, Li ZJ, Wang SW, Wang SM, Huang DH, Li YH, Ma YY, Wang J, Liu F, Chen XD, Li GX, Wang XT, Wang ZQ, Zhao GQ.
    BMC Microbiol; 2012 Jul 28; 12():156. PubMed ID: 22838726
    [Abstract] [Full Text] [Related]

  • 20. Characterization of two bacteriophages specific to Acinetobacter baumannii and their effects on catheters biofilm.
    Erol HB, Kaskatepe B, Yildiz S, Altanlar N, Bayrakdar F.
    Cell Biochem Funct; 2024 Mar 28; 42(2):e3966. PubMed ID: 38444208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.